Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by FARR, B. M.
Right arrow Articles by GWALTNEY, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FARR, B. M.
Right arrow Articles by GWALTNEY, J. M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 128, No. 5: 1162-1172
Copyright © 1988 by The Johns Hopkins University School of Hygiene and Public Health


research-article

TWO RANDOMIZED CONTROLLED TRIALS OF VIRUCIDAL NASAL TISSUES IN THE PREVENTION OF NATURAL UPPER RESPIRATORY INFECTIONS

BARRY M. FARR1,, J. O. HENDLEY2, D. L. KAISER1 and JACK M. GWALTNEY1

1Department of Internal Medicine, University of Virginia School of Medicine Charlottesville, VA
2Department of Pediatrics, University of Virginia School of Medicine Charlottesville, VA

Reprint requests to Dr. Barry M. Farr, Department of Internal Medicine, University of Virginia School of Medicine, Box 473, Charlottesville, VA 22908

Two six-month randomized, controlled double-blind trials of the efficacy of virucidal nasal tissues in the prevention of natural colds were conducted in Chariottesville, Virginia, between 1983 and 1986. Tissues impregnated with malic and citric acids and sodium lauryl sulfate were used in both trials. Placebo tissues contained saccharin in the first trial and a mixture including succinic acid in the second. A total of 186 families were evaluable after completion of trial I, and 98 families were evaluable in trial II. The antiviral tissues were associated with 14 and 5% relative reductions in the overall rate of colds in the first and second trials, respectively. In the first study, this appeared to be due to an appropriate fall in secondary illnesses with a relative reduction in the ratio of secondary to primary illnesses of 32%. In trial II, however, the small and statistically insignificant reduction was primarily due to a drop in the rate of primary illness (which cannot be attributed to tissue efficacy), and the ratio of secondary to primary illness was actually 5% higher in the group with active tissues than in the placebo group. We conclude that when rigorously used in a study protocol, virucidal tissues may offer a modest reduction of secondary colds in the home, but for reasons currently unknown, do not have a major effect on the overall rate of colds.

common cold; research design


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BMJHome page
T. Jefferson, C. Del Mar, L. Dooley, E. Ferroni, L. A Al-Ansary, G. A Bawazeer, M. L van Driel, R. Foxlee, and A. Rivetti
Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review
BMJ, September 21, 2009; 339(sep21_1): b3675 - b3675.
[Abstract] [Full Text] [PDF]


Home page
AJPHHome page
A. Donner and N. Klar
Pitfalls of and Controversies in Cluster Randomization Trials
Am J Public Health, March 1, 2004; 94(3): 416 - 422.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. Roberts, E. PhD, W. Smith, L. Jorm, M. Patel, R. M. Douglas, and C. McGilchrist
Effect of Infection Control Measures on the Frequency of Upper Respiratory Infection in Child Care: A Randomized, Controlled Trial
Pediatrics, April 1, 2000; 105(4): 738 - 742.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.